Clinical Trial Update: Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma [Phase 3]

View source ↗

Summary

Phase 3 trial comparing carfilzomib plus lenalidomide and dexamethasone (CRd) versus lenalidomide and dexamethasone (Rd) in relapsed multiple myeloma; study com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Carfilzomib (carfilzomib)
• DEXAMETHASONE (Dexamethasone)
• Lenalidomide (lenalidomide)

Snippet

Sponsor: Amgen | Conditions: Relapsed Multiple Myeloma | Phase 3 | Status: COMPLETED | Results posted: 2015-07-08